MET and glioblastoma: The target proteins chosen by CAR-T cells were preferred based on their high expression in glioblastoma and their high involvement in pathways that are often altered in cancer cells; the three investigated proteins are AXL, mesenchymal-epithelial transition factor (c-Met) and Folate receptor 1 (FORL1).